Top Markets
Coin of the day
PRISM BioLab Co.,LTD PRISM BioLab Co.,LTD

PRISM BioLab Co.,LTD

206A
Rang in aandelen #26417
PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying... PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying and advancing small molecule compounds. Its core mission involves modulating protein-protein interactions. The company leverages a proprietary protein secondary structure mimetic library to regulate interactions between proteins within cells. A key product in its development pipeline is PRI-724, an anti-cancer CP/Catenin inhibitor. This drug targets both mature cancer cells and cancer stem cells, inducing them to transition from uncontrolled proliferation to differentiation. Hiroyuki Kouji founded the organization on November 2, 2006, and it is headquartered in Fujisawa, Japan.
Aandeelprijs
$1.10
Marktkapitalisatie
$40.76M
Verandering (1 dag)
3.68%
Verandering (1 jaar)
-13.12%
Land
JP
Handel PRISM BioLab Co.,LTD (206A)

Categorie

Dividendrendementgeschiedenis voor PRISM BioLab Co.,LTD (206A)
Het dividendrendement (TTM) van PRISM BioLab Co.,LTD (aandelsymbool: 206A) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van PRISM BioLab Co.,LTD (206A) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH